#National Institutes of Health

With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.

Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.

The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.

NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.

The benefits of achieving herd immunity thresholds have been less successful with respiratory viruses that continually mutate.

Studies found that COVID-19 vaccines elicit T cells that recognize the Omicron variant despite the many mutations in its spike protein.

Infection with EBV dramatically increased the odds of developing multiple sclerosis, suggesting vaccines could help prevent it.

Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.

An NIH-sponsored study assessed boosters for adults fully vaccinated with any authorized or approved COVID-19 vaccine.

SARS-CoV-2 will probably continue to circulate indefinitely, and animal coronaviruses may emerge at any time.

Stop by our virtual booth at USCHA and watch the speeches and listening sessions we’re participating in.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.

Collins has led the NIH under three presidents over more than 12 years.

The removal of “AIDS” from the names of two CDC HIV agencies coincides with structural changes.

NIH-funded study finds reduced levels of HIV in bone marrow, spleen and brain after nanoparticle therapy.

About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.